These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9304410)

  • 21. Comparative study on alpha 1-adrenoceptor antagonist binding in human prostate and aorta.
    Yamada S; Suzuki M; Tanaka C; Mori R; Kimura R; Inagaki O; Honda K; Asano M; Takenaka T; Kawabe K
    Clin Exp Pharmacol Physiol; 1994 May; 21(5):405-11. PubMed ID: 7955549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological properties of the cloned alpha 1A/D-adrenoceptor subtype are consistent with the alpha 1A-adrenoceptor characterized in rat cerebral cortex and vas deferens.
    Kenny BA; Naylor AM; Greengrass PM; Russell MJ; Friend SJ; Read AM; Wyllie MG
    Br J Pharmacol; 1994 Apr; 111(4):1003-8. PubMed ID: 7913370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [3H]R-terazosin binds selectively to alpha1-adrenoceptors over alpha2-adrenoceptors - comparison with racemic [3H]terazosin and [3H]prazosin.
    Ireland LM; Cain JC; Rotert G; Thomas S; Shoghi S; Hancock AA; Kerwin JF
    Eur J Pharmacol; 1997 May; 327(1):79-86. PubMed ID: 9185839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study on pharmacokinetics and in vivo alpha1-adrenoceptor binding of [3H]tamsulosin and [3H]prazosin in rats.
    Ohkura T; Yamada S; Deguchi Y; Kimura R
    Biol Pharm Bull; 1999 Apr; 22(4):412-7. PubMed ID: 10328564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha1-adrenoceptor subtype substitution in knockout mice.
    Hieble JP
    Br J Pharmacol; 2004 Jul; 142(6):919. PubMed ID: 15210582
    [No Abstract]   [Full Text] [Related]  

  • 26. Characterization of specific binding of [125I]L-762,459, a selective alpha1A-adrenoceptor radioligand to rat and human tissues.
    O'Malley SS; Chen TB; Francis BE; Gibson RE; Burns HD; DiSalvo J; Bayne ML; Wetzel JM; Nagarathnam D; Marzabadi M; Gluchowski C; Chang RS
    Eur J Pharmacol; 1998 May; 348(2-3):287-95. PubMed ID: 9652345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of alpha 1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies.
    Ohmura T; Oshita M; Kigoshi S; Muramatsu I
    Br J Pharmacol; 1992 Nov; 107(3):697-704. PubMed ID: 1361871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo measurement by [3H]Tamsulosin of alpha1 adrenoceptors in rat tissues in relation to the pharmacokinetics.
    Yamada S; Ohkura T; Deguchi Y; Kimura R
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1575-83. PubMed ID: 10336555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro alpha1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel alpha1A-adrenoceptor selective antagonists.
    Williams TJ; Blue DR; Daniels DV; Davis B; Elworthy T; Gever JR; Kava MS; Morgans D; Padilla F; Tassa S; Vimont RL; Chapple CR; Chess-Williams R; Eglen RM; Clarke DE; Ford AP
    Br J Pharmacol; 1999 May; 127(1):252-8. PubMed ID: 10369480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional and radioligand binding characterization of the α1L-adrenoceptor subtype of the human vas deferens.
    Davis BJ; Wiener M; Chapple CR; Sellers DJ; Chess-Williams R
    Auton Autacoid Pharmacol; 2015 Apr; 34(3-4):41-9. PubMed ID: 25790239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-affinity specific [3H]tamsulosin binding to alpha 1-adrenoceptors in human prostates with benign prostatic hypertrophy.
    Yamada S; Tanaka C; Ohkura T; Mori R; Kimura R; Inagaki O; Honda K; Kawabe K
    Urol Res; 1994; 22(5):273-8. PubMed ID: 7533443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radioreceptor assay analysis of tamsulosin and terazosin pharmacokinetics.
    Taguchi K; Schäfers RF; Michel MC
    Br J Clin Pharmacol; 1998 Jan; 45(1):49-55. PubMed ID: 9489594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of alpha1-adrenoceptor occupancy in the human prostate from plasma concentrations of silodosin, tamsulosin and terazosin to treat urinary obstruction in benign prostatic hyperplasia.
    Yamada S; Kato Y; Okura T; Kagawa Y; Kawabe K
    Biol Pharm Bull; 2007 Jul; 30(7):1237-41. PubMed ID: 17603160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding characteristics of alpha 1-adrenoceptors in bovine prostate using a radioligand binding assay.
    Maruyama K; Kinami J; Tsuchihashi H; Nagatomo T
    J Pharmacobiodyn; 1991 Jun; 14(6):315-9. PubMed ID: 1686059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of binding sites of prazosin, tamsulosin and KMD-3213 with alpha(1)-adrenergic receptor subtypes by molecular modeling.
    Ishiguro M; Futabayashi Y; Ohnuki T; Ahmed M; Muramatsu I; Nagatomo T
    Life Sci; 2002 Oct; 71(21):2531-41. PubMed ID: 12270758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of prazosin, terazosin and tamsulosin: functional and binding studies in isolated prostatic and vascular human tissues.
    Amadesi S; Varani K; Spisani L; Daniele C; Turini A; Agnello G; Zamboni P; Borea PA; Geppetti P
    Prostate; 2001 Jun; 47(4):231-8. PubMed ID: 11398170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional identification of alpha 1-adrenoceptor subtypes in human prostate: comparison with those in rat vas deferens and spleen.
    Teng CM; Guh JH; Ko FN
    Eur J Pharmacol; 1994 Nov; 265(1-2):61-6. PubMed ID: 7883030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative imaging in live human cells reveals intracellular alpha(1)-adrenoceptor ligand-binding sites.
    Mackenzie JF; Daly CJ; Pediani JD; McGrath JC
    J Pharmacol Exp Ther; 2000 Aug; 294(2):434-43. PubMed ID: 10900216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological analysis of the novel, selective alpha1-adrenoceptor antagonist, KMD-3213, and its suitability as a tritiated radioligand.
    Murata S; Taniguchi T; Muramatsu I
    Br J Pharmacol; 1999 May; 127(1):19-26. PubMed ID: 10369451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo demonstration of alpha(1A)-adrenoceptor subtype selectivity of KMD-3213 in rat tissues.
    Yamada S; Okura T; Kimura R
    J Pharmacol Exp Ther; 2001 Jan; 296(1):160-7. PubMed ID: 11123376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.